These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8800296)
1. Skin ultrastructure after calcipotriol treatment: a transmission electron microscopic and freeze-fracture study on psoriatic patients. Cavicchini S; Brezzi A; Gasparini G; Caputo R Acta Derm Venereol; 1996 May; 76(3):186-9. PubMed ID: 8800296 [TBL] [Abstract][Full Text] [Related]
2. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279 [TBL] [Abstract][Full Text] [Related]
3. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients. Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128 [TBL] [Abstract][Full Text] [Related]
4. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment. Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis. El-Domyati M; Barakat M; Abdel-Razek R; El-Din Anbar T Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673 [TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559 [TBL] [Abstract][Full Text] [Related]
7. Topical calcipotriol in the treatment of intertriginous psoriasis. Kienbaum S; Lehmann P; Ruzicka T Br J Dermatol; 1996 Oct; 135(4):647-50. PubMed ID: 8915166 [TBL] [Abstract][Full Text] [Related]
8. Calcipotriol ointment versus cream in psoriasis vulgaris. Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018 [TBL] [Abstract][Full Text] [Related]
9. Microcirculatory modifications of psoriatic lesions during topical therapy. Rosina P; Giovannini A; Gisondi P; Girolomoni G Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121 [TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
11. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol. Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256 [TBL] [Abstract][Full Text] [Related]
12. Structural alterations of basal keratinocytes and capillary loop in psoriasis during treatment with topical calcipotriol. Palleschi GM; Gentili A; Caproni M; Giacomelli A; Falcos D; Fabbri P Acta Derm Venereol Suppl (Stockh); 1994; 186():49-51. PubMed ID: 8073836 [TBL] [Abstract][Full Text] [Related]
13. Proactive treatment with calcipotriol reduces recurrence of plaque psoriasis. Ito K; Koga M; Shibayama Y; Tatematsu S; Nakayama J; Imafuku S J Dermatol; 2016 Apr; 43(4):402-5. PubMed ID: 26434738 [TBL] [Abstract][Full Text] [Related]
14. Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis. Roussaki-Schulze AV; Kouskoukis C; Klimi E; Zafiriou E; Galanos A; Rallis E Drugs Exp Clin Res; 2005; 31(5-6):169-74. PubMed ID: 16425972 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis. Singh P; Gupta S; Abidi A; Krishna A J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159 [TBL] [Abstract][Full Text] [Related]
16. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions. van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604 [TBL] [Abstract][Full Text] [Related]
17. Calcipotriol cream in the treatment of flexural psoriasis. Duweb GA; Eldebani S; Alhaddar J Int J Tissue React; 2003; 25(4):127-30. PubMed ID: 15244317 [TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Molin L; Cutler TP; Helander I; Nyfors B; Downes N Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301 [TBL] [Abstract][Full Text] [Related]
19. UVB versus UVB plus calcipotriol (MC 903) therapy for psoriasis vulgaris. Kokelj F; Lavaroni G; Guadagnini A Acta Derm Venereol; 1995 Sep; 75(5):386-7. PubMed ID: 8615059 [TBL] [Abstract][Full Text] [Related]
20. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]